Applied Molecular Transport Inc. (AMTI) Financial Statements (2023 and earlier)

Company Profile

Business Address 450 EAST JAMIE COURT
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments61,145159,821129,869
Cash and cash equivalents61,145159,8215,843
Short-term investments   124,026
Prepaid expense2,6886,6851,311
Other current assets186594321
Other undisclosed current assets   
Total current assets:64,019167,100131,501
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization584652 
Operating lease, right-of-use asset33,22238,142 
Property, plant and equipment8,1836,9988,447
Restricted cash and investments9161,025108
Other noncurrent assets522121127
Total noncurrent assets:43,42746,9388,682
TOTAL ASSETS:107,446214,038140,183
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,24310,4377,347
Accounts payable1,5832,2113,174
Accrued liabilities8,6608,2264,173
Debt205237 
Deferred rent credit   83
Other undisclosed current liabilities4,6393,584232
Total current liabilities:15,08714,2587,662
Noncurrent Liabilities
Long-term debt and lease obligation4935,952 
Finance lease, liability49167 
Liabilities, other than long-term debt31,472241444
Deferred rent credit   444
Other liabilities 244241 
Operating lease, liability31,22835,785 
Other undisclosed noncurrent liabilities  404
Total noncurrent liabilities:31,52136,193848
Total liabilities:46,60850,4518,510
Equity
Equity, attributable to parent60,838163,587131,673
Common stock444
Additional paid in capital426,804403,228271,000
Accumulated other comprehensive income   27
Accumulated deficit(365,970)(239,645)(139,358)
Total equity:60,838163,587131,673
TOTAL LIABILITIES AND EQUITY:107,446214,038140,183

Income Statement (P&L) ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues2,446  
Sublease income 2,446  
Gross profit: 2,446  
Operating expenses(127,219)(100,789)(66,682)
Other undisclosed operating loss (2,446)  
Operating loss:(127,219)(100,789)(66,682)
Nonoperating income894502118
Investment income, nonoperating 898626229
Other nonoperating expense(4)(124)(111)
Interest and debt expense(27)(32) 
Loss from continuing operations:(126,352)(100,319)(66,564)
Loss before gain (loss) on sale of properties:(100,319)(66,564)
Other undisclosed net income2732 
Net loss:(126,325)(100,287)(66,564)
Other undisclosed net income attributable to parent   
Net loss attributable to parent:(126,325)(100,287)(66,564)
Preferred stock dividends and other adjustments   (105,615)
Net loss available to common stockholders, diluted:(126,325)(100,287)(172,179)

Comprehensive Income ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(126,325)(100,287)(66,564)
Comprehensive loss:(126,325)(100,287)(66,564)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (27)14
Comprehensive loss, net of tax, attributable to parent:(126,325)(100,314)(66,550)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: